|
Apr 3
|
Exact Sciences' (EXAS) Oncoguard Esophagus Test Looks Promising
|
|
Apr 3
|
Veeva Systems' (VEEV) CFO Resignation Sparks 6% Stock Drop
|
|
Apr 2
|
Baxter's (BAX) Latest FDA Approval to Boost Infusion Therapy
|
|
Apr 2
|
Three Reasons to Retain Avanos (AVNS) Stock in Your Portfolio
|
|
Apr 2
|
AngioDynamics (ANGO) Settles Patent Litigations With BD
|
|
Apr 2
|
Prestige Consumer (PBH) Banks on its Portfolio Amid Cost Woes
|
|
Apr 2
|
Thermo Fisher (TMO) Debuts a New In-Line Metrology Solution
|
|
Apr 1
|
Three Reasons to Retain Revvity (RVTY) Stock in Your Portfolio
|
|
Apr 1
|
OPKO Health (OPK) to Restructure After Asset Buyout by Labcorp
|
|
Apr 1
|
Neuronetics' (STIM) FDA-Cleared NeuroStar to Aid in Depression
|
|
Apr 1
|
Tandem Diabetes (TNDM) Gains From Innovation Amid Macro Issues
|
|
Apr 1
|
Paragon 28 (FNA) Expands Syndesmotic Repair Line With New Launch
|
|
Apr 1
|
Medtronic's (MDT) Newest Evolut TAVR System Gets FDA Approval
|
|
Mar 28
|
Chemed (CHE) Up 2.5% Since Last Earnings Report: Can It Continue?
|
|
Mar 28
|
GE HealthCare's (GEHC) PVA to Aid in Capturing Prostate Volume
|
|
Mar 28
|
3 Reasons to Retain Inogen (INGN) Stock in Your Portfolio
|
|
Mar 28
|
Boston Scientific (BSX) and Scivita Medical Expand Partnership
|
|
Mar 27
|
Accuray's (ARAY) CyberKnife Improves Prostate Cancer Treatment
|
|
Mar 27
|
DexCom (DXCM) Hits 52-Week High: What's Driving the Stock?
|
|
Mar 27
|
Stryker's (SYK) Latest Launch to Streamline Procedural Workflows
|